en.aazsante.fr

The Largest Portal Of Health And Quality Of Life.

Multivacination campaign begins next Monday

Multivacination campaign begins next Monday

It was released on Tuesday (13 ), by the Minister of Health, Ricardo Barros, the National Multivacination Campaign 2016. The campaign aims to make parents or guardians update the vaccination portfolios of their children, especially children under 5 years, children of 9 years and adolescents between the ages of 10 and 15.

The Ministry of Health sent 19.2 million extra doses of 14 vaccines to health posts nationwide. Ricardo Barros explained that the inclusion of adolescents is because this group is more resistant to vaccination, and many parents believe that there is no need to immunize children in this age group.

The campaign will start next Monday (19) and has its closure on September 30, having as day of national mobilization on the 24th. In total, 26.8 million doses were sent throughout Brazil, both for routine vaccination in September (7.6 million doses) and extra doses.

CHANGES IN THE CALENDAR - In January 2016, the ministry promoted changes in the vaccination schedule of four vaccines: poliomyelitis, HPV, meningococcal C (conjugated) and 10-valent pneumococcal. The National Vaccination Calendar has routine and periodic changes due to changes in the epidemiological situation, indications of vaccines or the incorporation of new vaccines. Check the changes this year:

POLIOMIELITE - The vaccination schedule against polio became three doses of the injectable vaccine - VIP (2, 4 and 6 months) and another two booster doses with the oral vaccine - VOP (droplet). By 2015, the scheme was two injectables (VIP) and three oral (VOP). The change is in line with the guidance of the World Health Organization (WHO) and as part of the global polio eradication process. It is worth noting that this substitution does not affect the protection of the children, who are already immunized with the three injectable doses.

HPV - The vaccination schedule increased from three to two doses, with a six-month interval between them. Recent studies show that the two-dose schedule shows an antibody response in healthy girls ages 9 to 14 years compared to the immune response of 15- to 25-year-old women who received three doses. Women living with HIV between 9 and 26 years should continue to receive the three-dose regimen.

MENINGOCÓCICA - The booster, which was previously given at 15 months, was administered at 12 months, preferably made up to 4 years. The first doses of meningococcal continue to be performed at 3 and 5 months.

PNEUMOCÓCICA - Reduction of one dose in the 10-valent pneumococcal vaccine. It was administered in two doses, at 2 and 4 months, with a reinforcement preferably at 12 months, which can be received up to 4 years. This recommendation was also made because the studies show that the two-dose regimen plus one boost has the same effectiveness as the three-dose regimen plus a booster.


Federal Court bans sale of medicine for childhood leukemia

Federal Court bans sale of medicine for childhood leukemia

The decision was made by Judge Rolando Valcir Spanholo, of the 21st Federal Court in Brasilia, an application made by the Federal Public Ministry (MPF / DF). The Ministry of Health will have 45 days to purchase another medicine to replace the Chinese medicine, with the active ingredient L- Asparaginase, which presents scientific evidence on its efficacy and safety, following the rules of indexed technical-scientific literature.

(Health)

Anvisa prohibits sale of thermometers and devices with mercury

Anvisa prohibits sale of thermometers and devices with mercury

The National Health Surveillance Agency (Anvisa) has approved a resolution prohibiting the manufacture, import and marketing of thermometers and pressure devices have mercury. The measure was unanimously approved by the Collegiate Board of the body on Tuesday, March 7. With the decision, manufacturing companies, private health agencies and the Unified Health System will have to meet the requirements until the day January 1, 2019.

(Health)